Abstract
Blue Gene is a massively parallel computer being developed at the IBM Thomas J. Watson Research Center. Blue Gene represents a hundred-fold improvement on performance compared with the fastest supercomputers of today. It will achieve 1 PetaFLOP/sec through unprecedented levels of parallelism in excess of 4,0000,000 threads of execution. The Blue Gene project has two important goals, in which understanding of biologically import processes will be advanced, as well as advancement of knowledge of cellular architectures (massively parallel system built of single chip cells that integrate processors, memory and communication), and of the software needed to exploit those effectively. This massively parallel system of 65,536 nodes is based on a new architecture that exploits system-on-a-chip technology to deliver target peak processing power of 360 teraFLOPS (trillion floating-point operations per second). The machine is scheduled to be operational in the 2004-2005 time frame, at price/performance and power consumption/performance targets unobtainable with conventional architectures.
refer:
Blue Gene Technology PPT 1
Blue Gene Technology PPT 2
Blue Gene Technology PPT 3
Ibm Blue Gene
Blue Gene is a massively parallel computer being developed at the IBM Thomas J. Watson Research Center. Blue Gene represents a hundred-fold improvement on performance compared with the fastest supercomputers of today. It will achieve 1 PetaFLOP/sec through unprecedented levels of parallelism in excess of 4,0000,000 threads of execution. The Blue Gene project has two important goals, in which understanding of biologically import processes will be advanced, as well as advancement of knowledge of cellular architectures (massively parallel system built of single chip cells that integrate processors, memory and communication), and of the software needed to exploit those effectively. This massively parallel system of 65,536 nodes is based on a new architecture that exploits system-on-a-chip technology to deliver target peak processing power of 360 teraFLOPS (trillion floating-point operations per second). The machine is scheduled to be operational in the 2004-2005 time frame, at price/performance and power consumption/performance targets unobtainable with conventional architectures.
refer:
Blue Gene Technology PPT 1
Blue Gene Technology PPT 2
Blue Gene Technology PPT 3
Ibm Blue Gene
The IBM Blue Gene series of energy-efficient supercomputers has been named the Medal of Technology and Innovation award winner, the highest honor for technological achievement for outstanding contributions related to the nation's competiveness, standard of living, and quality of life through the development and commercialization of technological products. The medal program is administered by the U.S. Patent and Trademark Office and is awarded annually to individuals, teams, and companies.
The Blue Gene leverages a high-performance, low-power, system-on-a-chip architecture offering extreme integration that dramatically improves reliability increases energy efficiency and reduces operating costs. Much of the software needed to operate Blue Gene comes from the open source community and was developed by laboratories and universities around the world. Argonne National Labs was involved in fostering that community as well as developing key components of the system software. For example, the Blue Gene leverages Argonne's MPICH, the version of the Message Passing Interface that scientists use to write parallel programs capable of scaling to hundreds of thousands of CPU cores. Computer scientists are also working on extending the capabilities of Blue Gene with advanced math libraries, improved parallel file systems, and even experimental operating systems such as ZeptoOS, which permits users to run Linux on the Blue Gene's compute nodes.
"The Blue Gene supercomputers are an outstanding example of our investment in nuclear security providing the tools to tackle broader national challenges," said NNSA Administrator Thomas D'Agostino. "This machine, which was originally developed to ensure the safety and reliability of our nuclear stockpile without testing, has led to amazing advances in science and discovery."
The U.S. Department of Energy began an R&D partnership with IBM in 2001 to develop the Blue Gene platform. Argonne National Lab and Lawrence Livermore National Lab worked on key aspects of the design and provided critical software components to ensure it was well suited to solve challenges in energy, the environment and national security.
I was working and suddenly I visits your site frequently and recommended it to me to read also. The writing style is superior and the content is relevant. Thanks for the insight you provide the readers!
ReplyDeletefacebook entrar
facebook entrar iniciar sesion
facebook en espaƱol descargar
facebook entrar direto agora